Related references
Note: Only part of the references are listed.Therapeutic Role of Tamoxifen for Triple-Negative Breast Cancer: Leveraging the Interaction Between ERβ and Mutant p53
Lauren Scarpetti et al.
ONCOLOGIST (2023)
The Role of Extracellular Matrix Proteins in Breast Cancer
Arkadiusz Lepucki et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Clinical translation of patient-derived tumour organoids- bottlenecks and strategies
Malia Alexandra Foo et al.
BIOMARKER RESEARCH (2022)
A Platform of Patient-Derived Microtumors Identifies Individual Treatment Responses and Therapeutic Vulnerabilities in Ovarian Cancer
Nicole Anderle et al.
CANCERS (2022)
Recent advances in organotypic tissue slice cultures for anticancer drug development
Lin He et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2022)
Breast cancer as an example of tumour heterogeneity and tumour cell plasticity during malignant progression
Fabiana Luond et al.
BRITISH JOURNAL OF CANCER (2021)
Patient-Derived Explants as a Precision Medicine Patient-Proximal Testing Platform Informing Cancer Management
Abby R. Templeton et al.
FRONTIERS IN ONCOLOGY (2021)
Targeting CSF1R Alone or in Combination with PD1 in Experimental Glioma
Justyna M. Przystal et al.
CANCERS (2021)
New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities
Milad Ashrafizadeh et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Dichotomous role of microtubule associated protein tau as a biomarker of response to and a target for increasing efficacy of taxane treatment in cancers of epithelial origin
Maria Barbolina
PHARMACOLOGICAL RESEARCH (2021)
Activation of the eIF2α/ATF4 axis drives triple-negative breast cancer radioresistance by promoting glutathione biosynthesis
Xupeng Bai et al.
REDOX BIOLOGY (2021)
Argyrin F Treatment-Induced Vulnerabilities Lead to a Novel Combination Therapy in Experimental Glioma
Bianca Walter et al.
ADVANCED THERAPEUTICS (2021)
FGFR1 Is Associated With Tamoxifen Resistance and Poor Prognosis of ER-Positive Breast Cancers by Suppressing ER Protein Expression
Qing Lv et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2021)
Invasive lobular carcinoma of the breast: the increasing importance of this special subtype
Amy E. McCart Reed et al.
BREAST CANCER RESEARCH (2021)
Molecular Classification of Breast Cancer
Julia Y. S. Tsang et al.
ADVANCES IN ANATOMIC PATHOLOGY (2020)
Inactivating NF1 Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy Resistance
Alex Pearson et al.
CLINICAL CANCER RESEARCH (2020)
Unraveling Triple-Negative Breast Cancer Tumor Microenvironment Heterogeneity: Towards an Optimized Treatment Approach
Yacine Bareche et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2020)
Cytokeratin 5 alters β-catenin dynamics in breast cancer cells
Olivia McGinn et al.
ONCOGENE (2020)
Neoadjuvant atezolizumab and chemotherapy in patients with resectable non-small-cell lung cancer: an open-label, multicentre, single-arm, phase 2 trial
Catherine A. Shu et al.
LANCET ONCOLOGY (2020)
The NF-κB Pathway Promotes Tamoxifen Tolerance and Disease Recurrence in Estrogen Receptor-Positive Breast Cancers
Irida Kastrati et al.
MOLECULAR CANCER RESEARCH (2020)
Fine-Needle Aspiration-Based Patient-Derived Cancer Organoids
Anna E. Vilgelm et al.
ISCIENCE (2020)
Downregulation of cytokeratin 18 induces cellular partial EMT and stemness through increasing EpCAM expression in breast cancer
Ruizan Shi et al.
CELLULAR SIGNALLING (2020)
Breast Cancer Organoids Model Patient-Specific Response to Drug Treatment
Elena Campaner et al.
CANCERS (2020)
Hyperactive CDK2 Activity in Basal-like Breast Cancer Imposes a Genome Integrity Liability that Can Be Exploited by Targeting DNA Polymerase ε
Vladislav O. Sviderskiy et al.
MOLECULAR CELL (2020)
Extracellular Matrix in the Tumor Microenvironment and Its Impact on Cancer Therapy
Erik Henke et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
Exploring Collagen Parameters in Pure Special Types of Invasive Breast Cancer
Rodrigo de Andrade Natal et al.
SCIENTIFIC REPORTS (2019)
Breast-lesions characterization using Quantitative Ultrasound features of peritumoral tissue
Ziemowit Klimonda et al.
SCIENTIFIC REPORTS (2019)
Single-cell transcriptomics reveals multi-step adaptations to endocrine therapy
Sung Pil Hong et al.
NATURE COMMUNICATIONS (2019)
Molecular mechanisms of resistance to CDK4/6 inhibitors in breast cancer: A review
Kamal Pandey et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Relevance of Spatial Heterogeneity of Immune Infiltration for Predicting Risk of Recurrence After Endocrine Therapy of ER plus Breast Cancer
Andreas Heindl et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Relevance of Spatial Heterogeneity of Immune Infiltration for Predicting Risk of Recurrence After Endocrine Therapy of ER plus Breast Cancer
Andreas Heindl et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Impact of multi-gene mutational profiling on clinical trial outcomes in metastatic breast cancer
Rossanna C. Pezo et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Change in Survival in Metastatic Breast Cancer with Treatment Advances: Meta-Analysis and Systematic Review
Jennifer L. Caswell-Jin et al.
JNCI CANCER SPECTRUM (2018)
Cross talk between progesterone receptors and retinoic acid receptors in regulation of cytokeratin 5-positive breast cancer cells
L. M. Fettig et al.
ONCOGENE (2017)
The relationship between breast cancer molecular subtypes and mast cell populations in tumor microenvironment
Anna Glajcar et al.
VIRCHOWS ARCHIV (2017)
Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine
Chantal Pauli et al.
CANCER DISCOVERY (2017)
A Review of Fulvestrant in Breast Cancer
Mark R. Nathan et al.
ONCOLOGY AND THERAPY (2017)
Expression of cancer-associated fibroblast-related proteins differs between invasive lobular carcinoma and invasive ductal carcinoma
Cheol Keun Park et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Targeting CDK4/6 in patients with cancer
Erika Hamilton et al.
CANCER TREATMENT REVIEWS (2016)
High CDK6 Protects Cells from Fulvestrant-Mediated Apoptosis and is a Predictor of Resistance to Fulvestrant in Estrogen Receptor-Positive Metastatic Breast Cancer
Carla L. Alves et al.
CLINICAL CANCER RESEARCH (2016)
The integrated stress response
Karolina Pakos-Zebrucka et al.
EMBO REPORTS (2016)
A bead-based western for high-throughput cellular signal transduction analyses
Fridolin Treindl et al.
NATURE COMMUNICATIONS (2016)
Microenvironmental Heterogeneity Parallels Breast Cancer Progression: A Histology-Genomic Integration Analysis
Rachael Natrajan et al.
PLOS MEDICINE (2016)
Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection
Brian D. Lehmann et al.
PLOS ONE (2016)
The Inositol Polyphosphate 5-Phosphatase PIPP Regulates AKT1-Dependent Breast Cancer Growth and Metastasis
Lisa M. Ooms et al.
CANCER CELL (2015)
Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer
Giovanni Ciriello et al.
CELL (2015)
Collagen density and alignment in responsive and resistant trastuzumab-treated breast cancer xenografts
Alex J. Walsh et al.
JOURNAL OF BIOMEDICAL OPTICS (2015)
Breast Tumor Heterogeneity: Source of Fitness, Hurdle for Therapy
Shany Koren et al.
MOLECULAR CELL (2015)
Targeting the translation machinery in cancer
Mamatha Bhat et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Analysis of PIK3CA Mutations and Activation Pathways in Triple Negative Breast Cancer
Paolo Cossu-Rocca et al.
PLOS ONE (2015)
Lobular breast cancer: molecular basis, mouse and cellular models
Matthias Christgen et al.
BREAST CANCER RESEARCH (2015)
Lobular Breast Cancer: Pathology, Biology, and Options for Clinical Intervention
Eva Vlug et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2014)
Enhancer Activation Requires trans-Recruitment of a Mega Transcription Factor Complex
Zhijie Liu et al.
CELL (2014)
Targeting the NFκB Signaling Pathways for Breast Cancer Prevention and Therapy
Wei Wang et al.
CURRENT MEDICINAL CHEMISTRY (2014)
Epithelial-to-Mesenchymal Transition Mediates Docetaxel Resistance and High Risk of Relapse in Prostate Cancer
Mercedes Marin-Aguilera et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Basal-Like and Triple-Negative Breast Cancers Searching for Positives Among Many Negatives
Prasanna Alluri et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2014)
Mitochondrial dysfunction in some triple-negative breast cancer cell lines: role of mTOR pathway and therapeutic potential
Helene Pelicano et al.
BREAST CANCER RESEARCH (2014)
Keratin 8 and 18 Loss in Epithelial Cancer Cells Increases Collective Cell Migration and Cisplatin Sensitivity through Claudin1 Up-regulation
Anne-Marie Fortier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
TP53 genomics predict higher clinical and pathologic tumor response in operable early-stage breast cancer treated with docetaxel-capecitabine ± trastuzumab
Stefan Glueck et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
Sohrab P. Shah et al.
NATURE (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
High ERK Protein Expression Levels Correlate with Shorter Survival in Triple-Negative Breast Cancer Patients
Chandra Bartholomeusz et al.
ONCOLOGIST (2012)
High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genes
Muhammad Riaz et al.
BREAST CANCER RESEARCH (2012)
Aligned Collagen Is a Prognostic Signature for Survival in Human Breast Carcinoma
Matthew W. Conklin et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
A comparative analysis of core needle biopsy and final excision for breast cancer: histology and marker expression
Matthew Ough et al.
AMERICAN JOURNAL OF SURGERY (2011)
Cytokeratin 5 positive cells represent a steroid receptor negative and therapy resistant subpopulation in luminal breast cancers
Peter Kabos et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Genomic predictors of response to doxorubicin versus docetaxel in primary breast cancer
M. Martin et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Therapeutic Resistance Resulting From Mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Signaling Pathways
James A. McCubrey et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2011)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Combinatorial Effects of Lapatinib and Rapamycin in Triple-Negative Breast Cancer Cells
Tongrui Liu et al.
MOLECULAR CANCER THERAPEUTICS (2011)
CDK1-dependent phosphorylation of EZH2 suppresses methylation of H3K27 and promotes osteogenic differentiation of human mesenchymal stem cells
Yongkun Wei et al.
NATURE CELL BIOLOGY (2011)
Retaining cell-cell contact enables preparation and culture of spheroids composed of pure primary cancer cells from colorectal cancer
Jumpei Kondo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Endocrine resistance associated with activated ErbB system in breast cancer cells is reversed by inhibiting MAPK or PI3K/Akt signaling pathways
Sandra E. Ghayad et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
IKKε Phosphorylation of Estrogen Receptor αSer-167 and Contribution to Tamoxifen Resistance in Breast Cancer
Jian-Ping Guo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Triple-negative breast cancer: disease entity or title of convenience?
Lisa Carey et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Clinicopathological features of the triple-negative tumors in Chinese breast cancer patients
Wen-Jin Yin et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Hazard of recurrence and adjuvant treatment effects over time in lymph node-negative breast cancer
James J. Dignam et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Regulation of Translation Initiation in Eukaryotes: Mechanisms and Biological Targets
Nahum Sonenberg et al.
CELL (2009)
Diagnostic Accuracy and Prognostic Value of Core Biopsy in the Management of Breast Cancer: A Series of 542 Patients
Christiane Richter-Ehrenstein et al.
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY (2009)
S6 Kinase 1 Regulates Estrogen Receptor α in Control of Breast Cancer Cell Proliferation
Rachel L. Yamnik et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Evaluation of Microtubule-Associated Protein-Tau Expression As a Prognostic and Predictive Marker in the NSABP-B 28 Randomized Clinical Trial
Lajos Pusztai et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Eukaryotic initiation factor 4E overexpression in triple-negative breast cancer predicts a worse outcome
Anthony Flowers et al.
SURGERY (2009)
The NF-κB Family of Transcription Factors and Its Regulation
Andrea Oeckinghaus et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2009)
Collagen density promotes mammary tumor initiation and progression
Paolo P. Provenzano et al.
BMC MEDICINE (2008)
Targeting the PI3K/Akt/mTOR pathway: Effective combinations and clinical considerations
Jaclyn LoPiccolo et al.
DRUG RESISTANCE UPDATES (2008)
The expression of cytokeratin 5/6 in invasive lobular carcinoma of the breast: evidence of a basal-like subset?
Oluwole Fadare et al.
HUMAN PATHOLOGY (2008)
Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibitors
L. S. Steelman et al.
ONCOGENE (2008)
MAPK overexpression is associated with anthracycline resistance and increased risk for recurrence in patients with triple-negative breast cancer
Y. Eralp et al.
ANNALS OF ONCOLOGY (2008)
Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome
A. Bergamaschi et al.
JOURNAL OF PATHOLOGY (2008)
Increased phosphorylation of Akt in triple-negative breast cancers
Shinobu Umemura et al.
CANCER SCIENCE (2007)
A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer
Karsten Gravdal et al.
CLINICAL CANCER RESEARCH (2007)
Nuclear factor-κB, an unappreciated tumor suppressor
Fei Chen et al.
CANCER RESEARCH (2007)
Triple-negative breast cancer: Clinical features and patterns of recurrence
Rebecca Dent et al.
CLINICAL CANCER RESEARCH (2007)
The triple negative paradox: Primary tumor chemosensitivity of breast cancer subtypes
Lisa A. Carey et al.
CLINICAL CANCER RESEARCH (2007)
Role of the progesterone receptor for paclitaxel resistance in primary breast cancer
M. Schmidt et al.
BRITISH JOURNAL OF CANCER (2007)
Hypoxia signalling in cancer and approaches to enforce tumour regression
Jacques Pouyssegur et al.
NATURE (2006)
Do the histologic features and results of breast cancer biomarker studies differ between core biopsy and surgical excision specimens?
Chandra N. Burge et al.
BREAST (2006)
Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas
SM Rodríguez-Pinilla et al.
CLINICAL CANCER RESEARCH (2006)
The oncogenic properties of mutant p110α and p110β phosphatidylinositol 3-kinases in human mammary epithelial cells
JJ Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis
R Mehra et al.
CANCER RESEARCH (2005)
Clinical response to neoadjuvant docetaxel predicts improved outcome in patients with large locally advanced breast cancers
YL Tham et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
Breast cancer molecular subtypes respond differently to preoperative chemotherapy
R Rouzier et al.
CLINICAL CANCER RESEARCH (2005)
Down-regulated expression of cytokeratin 18 promotes progression of human breast cancer
U Woelfle et al.
CLINICAL CANCER RESEARCH (2004)
The prognostic implication of the basal-like (cyclin Ehigh/p27low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer
WD Foulkes et al.
CANCER RESEARCH (2004)
Intragenic ERBB2 kinase mutations in tumours
P Stephens et al.
NATURE (2004)
Accuracy of typing and grading invasive mammary carcinomas on core needle biopsy compared with the excisional specimen
de Andrade VP et al.
VIRCHOWS ARCHIV (2004)
Systematic review of taxane-containing versus non-taxane-containing regimens for adjuvant and neoadjuvant treatment of early breast cancer
AK Nowak et al.
LANCET ONCOLOGY (2004)
Expression of luminal and basal cytokeratins in human breast carcinoma
DMA El-Rehim et al.
JOURNAL OF PATHOLOGY (2004)
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
TJ Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer
WD Foulkes et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Repeated observation of breast tumor subtypes in independent gene expression data sets
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Cytogenetic alterations and cytokeratin expression patterns in breast cancer: Integrating a new model of breast differentiation into cytogenetic pathways of breast carcinogenesis
E Korsching et al.
LABORATORY INVESTIGATION (2002)
Common adult stem cells in the human breast give rise to glandular and myoepithelial cell lineages:: A new cell biological concept
W Böcker et al.
LABORATORY INVESTIGATION (2002)
Direct evidence for a. role of beta-catenin/LEF-1 signaling pathway in induction of EMT
K Kim et al.
CELL BIOLOGY INTERNATIONAL (2002)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Cytochrome P450CYP1B1 protein expression: a novel mechanism of anticancer drug resistance
MCE McFadyen et al.
BIOCHEMICAL PHARMACOLOGY (2001)
Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor α -: A new model for anti-estrogen resistance
RA Campbell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Expression of the hepatocyte growth factor/c-Met pathway is increased at the cancer front in breast carcinoma
G Edakuni et al.
PATHOLOGY INTERNATIONAL (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Share Paper
